Complement-Based Drug Development Summit leaderboard
  • Monday, October 12, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Page 348

Azurity Pharmaceuticals Announces FDA Approval of Eprontia(TM) (Topiramate) Oral Solution

Nov 8, 2021
Azurity Pharmaceuticals, Inc. a private specialty pharmaceutical company focused on developing innovative products to meet the unique needs of patients with underserved conditions,…
Read More...

Ocugen Announces Submission of Emergency Use Authorization Request to the US FDA for Investigational…

Nov 8, 2021
Ocugen, Inc. a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics and vaccines, announced today that it has submitted a request to the…
Read More...

Green Circle Life Launches Covid-19 Vaccination Mandate Compliance Solution

Nov 4, 2021
Green Circle Life, provider of an all-in-one communication and engagement platform SmartFHR, has launched the Covid Passport, their end-to-end solution to help employers comply with an…
Read More...

Acticor Biotech Announces FDA Acceptance of IND Application for glenzocimab in Acute Ischemic Stroke

Nov 4, 2021
ACTICOR BIOTECH, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, announces that the U.S Food and Drug Administration (FDA) has provided…
Read More...

FDA Declines Emergency Use Authorization for ZYESAMI (aviptadil) for Patients with Critical COVID-19…

Nov 4, 2021
NRx Pharmaceuticals a clinical-stage biopharmaceutical company (NRx), today announced that the US Food and Drug Administration (FDA) has declined to issue an Emergency Use Authorization…
Read More...

Yokogawa Acquires Insilico Biotechnology, Developer of Innovative Bioprocess Digital Twin Technology

Nov 2, 2021
Yokogawa Electric Corporation  announces that it has acquired all shares of Insilico Biotechnology AG (“Insilico”), a Stuttgart, Germany-based developer and provider of bioprocess…
Read More...

Moderna and Metagenomi Establish Collaboration to Develop Next-Generation In Vivo Gene Editing…

Nov 2, 2021
Moderna Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Metagenomi, Inc., a genetic medicines company with a versatile portfolio of…
Read More...

Dunad Therapeutics enters Strategic Collaboration with Novartis to Develop Next-generation Oral…

Nov 2, 2021
Dunad Therapeutics ("Dunad"), a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies, announces that it has entered a…
Read More...

Venatorx Pharmaceuticals Announces Collaboration with Roche to Develop New Class of Antibiotics…

Nov 1, 2021
Venatorx Pharmaceuticals announced that it has entered into a Research Collaboration and License Agreement with Roche to discover, characterize and develop new small molecule inhibitors…
Read More...

Resverlogix In Active Discussions With The Kingdom of Morocco’s Ministry of Health For The Launch Of…

Nov 1, 2021
Resverlogix Corp. a world leader in epigenetics or gene regulation, is pleased to announce that it is in active discussions with the Kingdom of Morocco’s Ministry of Health for possible…
Read More...
Previous 1 … 346 347 348 349 350 … 957 Next
2nd Non-Opioid Pain Therapeutics Summit
Muscular Disorders Drug Development Summit
Amylin-Based Therapeutics Summit
Microbiome Movement USA Summit 2026
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
10th IPF Summit
PFS & Injectable Drug Devices Europe
Ophthalmic Drug Delivery Summit
Obesity & Weight Loss Drug Development Summit West
17th World ADC London
ADC Payload Summit 2026
10th Antifibrotic Drug Development Summit 2026
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
17th World ADC San Diego
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps
  • CSL, Alentis Partner on $1.55B Kidney and Liver Drug
  • Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B
  • KymaThera Raises $80M to Advance PI3Kα Cancer Drug
  • Industry Leaders Explore the Future of RNA Therapeutics Beyond Splicing

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Industry Leaders Explore the Future of RNA Therapeutics…

Direct RNA Binding Emerges as a Powerful Approach for…

AI, Structure Prediction and Advanced Computational Tools…

New Preclinical Data and Translational Advances Set to Take…

FDA, Health Canada & Leading Biopharma Organizations…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.